The truncated splice variant of peroxisome proliferator-activated receptor alpha, PPARα-tr, autonomously regulates proliferative and pro-inflammatory genes

Targeting Nuclear Receptors with Lentivirus-Delivered Small RNAs in Primary Human Hepatocytes

(2014) Maria Thomas et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Minireview: Challenges and Opportunities in Development of PPAR Agonists

(2014) Matthew B. Wright et al.   MOLECULAR ENDOCRINOLOGY

Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications - a review

(2014) Bogna Grygiel-Górniak   Nutrition Journal

Chimeric Mice with Hepatocyte-humanized Liver as an Appropriate Model to Study Human Peroxisome Proliferator–activated Receptor-α

(2014) Chise Tateno et al.   TOXICOLOGIC PATHOLOGY

Peroxisome proliferator-activated receptor-α activation and excess energy burning in hepatocarcinogenesis

(2013) Parimal Misra et al.   BIOCHIMIE

PPARα Activation Can Help Prevent and Treat Non–Small Cell Lung Cancer

(2013) Nataliya Skrypnyk et al.   CANCER RESEARCH

Human parenchymal and non-parenchymal liver cell isolation, culture and characterization

(2013) Georg Damm et al.   Hepatology International

Role of Myc in hepatocellular proliferation and hepatocarcinogenesis

(2013) Aijuan Qu et al.   JOURNAL OF HEPATOLOGY

Nuclear Control of the Inflammatory Response in Mammals by Peroxisome Proliferator-Activated Receptors

(2013) Stéphane Mandard et al.   PPAR Research

PPAR-α as a Key Nutritional and Environmental Sensor for Metabolic Adaptation

(2013) Alejandra V. Contreras et al.   Advances in Nutrition

PPARA: A Novel Genetic Determinant of CYP3A4 In Vitro and In Vivo

(2012) Kathrin Klein et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

PPARs at the crossroads of lipid signaling and inflammation

(2012) Walter Wahli et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Peroxisome proliferator-activated receptors and cancer: challenges and opportunities

(2011) Jihan Youssef et al.   BRITISH JOURNAL OF PHARMACOLOGY

Genomics of ADME gene expression: mapping expression quantitative trait loci relevant for absorption, distribution, metabolism and excretion of drugs in human liver

(2011) A Schröder et al.   PHARMACOGENOMICS JOURNAL

PPARs as therapeutic targets in cardiovascular disease

(2010) Marc van Bilsen et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Pathway-Targeted Pharmacogenomics of CYP1A2 in Human Liver

(2010) Kathrin Klein et al.   Frontiers in Pharmacology

Human glucocorticoid receptor isoform β: recent understanding of its potential implications in physiology and pathophysiology

(2009) Tomoshige Kino et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Genetic Variants of Wnt Transcription Factor TCF-4 (TCF7L2) Putative Promoter Region Are Associated with Small Intestinal Crohn's Disease

(2009) Maureen J. Koslowski et al.   PLoS One

Overexpression of human truncated peroxisome proliferator-activated receptor   induces apoptosis in HL-1 cardiomyocytes

(2008) J. Beaumont et al.   CARDIOVASCULAR RESEARCH

PPAR Modulators and PPAR Pan Agonists for Metabolic Diseases: The Next Generation of Drugs Targeting Peroxisome Proliferator-Activated Receptors?

(2008) P. Feldman et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Differential Regulation of Peroxisome Proliferator-Activated Receptor (PPAR)-α1 and Truncated PPARα2 as an Adaptive Response to Fasting in the Control of Hepatic Peroxisomal Fatty Acid β-Oxidation in the Hibernating Mammal

(2008) Zakaria El Kebbaj et al.   ENDOCRINOLOGY

High Throughput Gene Expression Measurement with Real Time PCR in a Microfluidic Dynamic Array

(2008) Sandra L. Spurgeon et al.   PLoS One

PPARα: Mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators

(2007) Frank J. Gonzalez et al.   TOXICOLOGY